Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Academy Sports and Outdoors: A Solid Investment or Just Another Regional Player?
Via The Motley Fool
Tickers ASO
Stocks And Precious Metals Charts - The Dollar Bounced Higher
Via Talk Markets
Verdant Commercial Capital Successfully Closes Fourth Asset-Backed Securitization for $400.6 Million
From Verdant Commercial Capital, LLC
Via Business Wire
Polar Cooling Portable AC Review (2025): Compact Air Conditioner Delivers Fast Relief Without Installation Hassles
Via ACCESS Newswire
3 Monster Stocks to Hold for the Next 20 Years
Via The Motley Fool
Topics World Trade
Exposures Tariff
Tickers BROS ONON SHOP
Why A 4.5% Nominal Rate Is Roughly Equilibrium…Hmmm, Sounds Familiar…
Via Talk Markets
Metanail Serum Pro Complex Review (2025): Natural Nail and Foot Care Serum for Strength, Hydration, and Repair
Via ACCESS Newswire
Inframark Expands Its Capabilities and Presence in Arizona, Adding Wastewater Experts Mehall Contracting
Via PRLog
BIMA, exSat Launch $100M Initiative To Expand Bitcoin-Backed DeFi Infrastructure
Via Benzinga
From Ancient Grounds to an Intelligent Future: The 1st International Humanoid Olympiad Launches in Olympia, Greece
From Acumino
Via Business Wire
Why Kingsoft Cloud Holdings Stock Plummeted by Nearly 8% Today
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KC
CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO)
From BioSig Technologies, Inc.
Via GlobeNewswire
Tickers BSGM
FilmHedge Is Letting A.I. Into the Deal Room—And Hollywood Will Never Be the Same
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence
Q1 2025 U.S. Retail Scorecard – Update
Via Talk Markets
3 Reasons Boeing Stock Is a Buy
Via The Motley Fool
Topics Earnings
Exposures Boeing 737 Financial
Tickers BA
+Attorney Ben Martin Earns Place on ‘Best Lawyers in Dallas’ List for 2025
From Ben Martin Law Group
Via Business Wire
Daniel Yomtobian on Leveraging Pandemic Shifts to Strengthen Brand Identity
Via Press Release Distribution Service
Topics Economy
Exposures COVID-19 Economy
Tickers IBM
Could Investing $10,000 in O'Reilly Automotive Make You a Millionaire?
Via The Motley Fool
Tickers ORLY
Empowering Postpartum Recovery: Midwife-Backed Momcozy Ergowrap Belly Band Earns Widespread Praise
Via Press Release Distribution Service
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Tickers KLAC
Diabetes Solution Kit Review (2025): Natural Program Offers Holistic Tools to Manage Blood Sugar Without Drugs
Via ACCESS Newswire
Semis Slip, Markets Swerve: Nvidia’s Pre-Earnings Wobble Jolts The Rally Ride
Via Talk Markets
Tickers NVDA
Gift Print Express Launches Rapid Custom Printing Platform for Every Occasion
Via Press Release Distribution Service
Spetz Announces Closing of First Tranche of Previously Announced $10,000,000 Private Placement
Via ACCESS Newswire
Tickers CSE:SPTZ DBKSF
This Warren Buffett Dividend Stock Is Crushing the S&P 500. Here's Why It's Still Worth Buying in June for Passive Income.
Via The Motley Fool
Topics Economy Stocks
Exposures Supply Chain US Equities
Tickers AAPL AXP BRK BRK-A
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
Tickers NPCE
Bernie Sanders Says, 'Trump Just Announced He's Reduced Drug Prices By 85%,' Dares You To Go To The Pharmacy And 'Tell Them Trump Sent You'
Via Benzinga
Topics Government
Exposures Political
Strategies That Stick Launches AI Marketing Bootcamp to Equip Nonprofits with Effective Growth Strategies
Via ACCESS Newswire
TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Tickers TEM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT
From Pomerantz LLP
Via GlobeNewswire
Tickers RCKT
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.